0
Skip to Content
SIOPEN Research Network
About SIOPEN
The History of SIOPEN
Executive Committee
Specialty Committees
SIOPEN Strategy 2023-28
Statements
Partnerships
Policies and SOPs
SIOPEN activities
SIOPEN Clinical Trials
Publications
Prioritization trial strategy in relapsed neuroblastoma
Events
Parents & Patients
Resources
Charities
Contact SIOPEN
SIOPEN members area
SIOPEN Research Network
About SIOPEN
The History of SIOPEN
Executive Committee
Specialty Committees
SIOPEN Strategy 2023-28
Statements
Partnerships
Policies and SOPs
SIOPEN activities
SIOPEN Clinical Trials
Publications
Prioritization trial strategy in relapsed neuroblastoma
Events
Parents & Patients
Resources
Charities
Contact SIOPEN
SIOPEN members area
Folder: About SIOPEN
Back
The History of SIOPEN
Executive Committee
Specialty Committees
SIOPEN Strategy 2023-28
Statements
Partnerships
Policies and SOPs
Folder: SIOPEN activities
Back
SIOPEN Clinical Trials
Publications
Prioritization trial strategy in relapsed neuroblastoma
Events
Folder: Parents & Patients
Back
Resources
Charities
Contact SIOPEN
SIOPEN members area

Full membership of SIOPEN is limited to healthcare professionals and scientists active within the fields of neuroblastoma clinical care and research. Prospective members will need to be confirmed by their National Deputy in the first instance (this may involve the need to supply a CV for review). All new members will be ratified by the Executive Committee and SIOPEN membership at the Annual General Meeting. Prior to confirmation of full membership, you can be provided with provisional membership that will allow to register for upcoming SIOPEN meetings

To become a SIOPEN member please click here

Disclaimer

The content provided on this website by SIOPEN (International Society of Paediatric Oncology Europe – Neuroblastoma) is intended solely for informational and educational purposes, particularly to support collaboration and research among healthcare professionals involved in the care of children with neuroblastoma.

This website is not intended for clinical use or for providing direct medical advice. It should not be used to guide individual patient care decisions.

We understand that parents and caregivers may come across this site during what is often a very difficult and overwhelming time. Please know that while SIOPEN is a network of healthcare professionals and researchers deeply committed to improving outcomes for children with neuroblastoma, we are not able to offer individual medical advice or respond directly to clinical questions from families via this platform.

If you are seeking guidance, we strongly encourage you to speak with your child’s medical team, who are best placed to support you. Where necessary, they may reach out to a national SIOPEN representative or external expert for further input.

SIOPEN is carefully exploring ways to help facilitate professional-to-professional connections, always with patient care, safety and ethical standards as our highest priorities.

Our Privacy Policy

The purpose of the Association is to perform and facilitate clinical, translational and basic research for children and adolescents with neuroblastoma in European countries as well as worldwide in order to improve the outcome of these patients.

SIOPEN Verein zur Förderung der Neuroblastomforschung is an Association registered in Austria and recognised as a non-profit organisation according to the Austrian Federal Tax Code.

Registration number ZVR 396592912

VAT no. ATU7132321

© SIOPEN Association